The US District Court for the District of Columbia has rejected Israel-headquartered Teva Pharmaceuticals Industries’ ...
U.S. Medicare price cuts of up to 85% will have a lesser impact on drugmakers than initially feared, with most of the hit ...
The U.S. District Court for the District of Columbia on Thursday rejected Teva Pharmaceuticals’ challenge to the Medicare ...
In recent days, Teva Pharmaceutical Industries received European Commission marketing authorizations for its denosumab ...
Teva Pharmaceuticals has recalled multiple lots of prazosin hydrochloride after detecting nitrosamine above FDA-approved ...
Janssen sued Teva in the US District Court for the District of New Jersey under the Hatch-Waxman Act after Teva filed an abbreviated new drug application (ANDA) on a generic version of Invega Sustenna ...
What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday outlined that Weiss executed a sale of 12,300 shares of Teva Pharmaceutical Indus with a total value of ...
Fintel on MSN
Teva Pharmaceutical Industries Limited - Depositary Receipt (TEVA) Price Target Increased by 16.51% to 0.06
The average one-year price target for Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) has been ...
Israel’s Teva Pharmaceutical Industries has announced that the European Commission (EC) has granted marketing authorizations ...
Teva has launched “Rise”, an open-innovation platform to partner with startups and tech firms in areas such as AI, digital ...
Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted ...
The positions in the table below reflect the Teva Pharmaceuticals USA, Inc.'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback